In this study, the knockdown of PAX3-FOXO1 in ARMS cell lines reduced the cell proliferation to approximately 60% in comparison to the control, which was partly in line with the previous reports suggesting that PAX3-FOXO1 alone is not responsible for the proliferative advantage. The gene discussed is FOXO1; the disease is alveolar rhabdomyosarcoma.